Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Inflammatory Breast Neoplasms × cobimetinib × Clear all

Sponsor

Conditions

Melanoma 9 Neoplasms 5 Colorectal Neoplasms 3 Urinary Bladder Neoplasms 2 Solid Tumors 2 Gastrointestinal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Thoracic Neoplasms 1 Solid Tumor 1 Skin Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Noonan Syndrome 1 Neoplasms, Unknown Primary 1 Neoplasms, Squamous Cell 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Microsatellite Unstable Colorectal Cancer 1 Lung Neoplasms 1 Lung Diseases 1 Gallbladder Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1

Interventions

Cyclophosphamide 11 Doxorubicin 7 Trastuzumab 6 Paclitaxel 6 Taxes 5 Radiotherapy 4 Epirubicin 4 Docetaxel 4 Carboplatin 4 Albumin-Bound Paclitaxel 4 pembrolizumab 3 Melphalan 3 pertuzumab 2 eribulin 2 Thiotepa 2 Tamoxifen 2 Peripheral Blood Stem Cell Transplantation 2 Lapatinib 2 Fluorouracil 2 Filgrastim 2 130-nm albumin-bound paclitaxel 2 trastuzumab biosimilar HLX02 1 talimogene laherparepvec 1 sargramostim 1 ruxolitinib 1 romidepsin 1 pazopanib 1 nintedanib 1 neratinib 1 grapiprant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡